---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-038045"
form_type: "8-K"
ticker: "FZMD"
cik: "0000319016"
company_name: "Fuse Medical, Inc."
filed_at: "2022-11-18T23:59:59+00:00"
generated_at: "2026-06-21T16:09:34.620855+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Fuse Medical Q3 net loss shrinks 99% to $9.4k; revenue up 7% to $4.5M

## Summary
- Net revenues $4.5M (+7% YoY); gross profit $3M (67% margin vs 56% in prior year).
- Net loss improved to $9,376 from $697,036 loss; loss reduced ~99% YoY.
- Adjusted EBITDA positive $131,241 vs loss of $630,549 in Q3 2021, a 121% improvement.
- Launched Fuse PSS Pedicle Screw System with minimally invasive options in Q3.
- Expects continued growth from new product launches and direct sales force expansion.

## SEC filing metadata
- accession: 0001564590-22-038045
- form_type: 8-K
- ticker: FZMD
- cik: 0000319016
- company_name: Fuse Medical, Inc.
- filed_at: 2022-11-18T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/319016/000156459022038045/0001564590-22-038045-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/319016/000156459022038045/fzmd-8k_20221115.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-038045
- JSON: https://secwatch.observer/filing/0001564590-22-038045.json
- Plain text: https://secwatch.observer/filing/0001564590-22-038045.txt

## Key facts
- Earnings Releases
  Fuse Medical, Inc. reported third quarter ended September 30, 2022 results: revenue $4.5 million, net income net loss was $9,376.
  - Period: third quarter ended September 30, 2022
  - Revenue: $4.5 million
  - Net income: net loss was $9,376
  - Result: reported results
  source text: Net revenues for the quarter ended September 30, 2022 were $4.5 million, compared to $4.2 million for the quarter ended September 30, 2021 which was an increase of approximately 7%.
  evidence_url: https://www.sec.gov/Archives/edgar/data/319016/000156459022038045/0001564590-22-038045-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.